US Patent 8183014 High affinity antibodies to human IL-6 receptor
Patent 8183014 was granted and assigned to Regeneron Pharmaceuticals, Inc. on May, 2012 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8183014 High affinity antibodies to human IL-6 receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
